Date of announcement 2023/11/20
Time of announcement 18:13:43
Date of events 2023/11/20
To which item it meets paragraph 21

1.Date of the shareholders meeting resolution:2023/11/20
2.Name and title of the director with permission to engage in competitive
conduct:Chun-Huei Ho / Chairman
3.Items of competitive conduct in which the director is permitted to engage:
T-E Pharma Holding / Director
4.Period of permission to engage in the competitive conduct:
During tenure of directorship.
5.Circumstances of the resolution (please describe the results of voting in
accordance with Article 209 of the Company Act):
Approved by the board of directors without the attendance of
the interested directors.
6.If the permitted competitive conduct belongs to the operator of a mainland
China area enterprise, the name and title of the directors
(if it is not the operator of a Mainland-area enterprise, please enter
“N/A” below):N/A
7.Company name of the mainland China area enterprise and the director's
position in the enterprise:N/A
8.Address of the mainland China area enterprise:N/A
9.Operations of the mainland China area enterprise:N/A
10.Impact on the company's finance and business:None
11.If the directors have invested in the mainland China area enterprise,
the monetary amount of the investment and their shareholding ratio:N/A
12.Any other matters that need to be specified:
The Board is authorized to exercise the rights of the shareholders’
meeting pursuant to Article 128-1 of the Company Act.